Pericytes from human non-small cell lung carcinomas: An attractive target for anti-angiogenic therapy
- 1 May 2006
- journal article
- Published by Elsevier in Microvascular Research
- Vol. 71 (3) , 163-174
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- Gene Expression Profiling in Non-Small Cell Lung CancerClinical Cancer Research, 2004
- VEGF coordinates interaction of pericytes and endothelial cells during vasculogenesis and experimental angiogenesisDevelopmental Dynamics, 2004
- Cancer without diseaseNature, 2004
- Endothelial-pericyte interactions in angiogenesisCell and tissue research, 2003
- Discovery of 5-[5-Fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic Acid (2-Diethylaminoethyl)amide, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial and Platelet-Derived Growth Factor Receptor Tyrosine KinaseJournal of Medicinal Chemistry, 2003
- The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumoursNeuropathology and Applied Neurobiology, 2002
- Isolation and in Vitro Characterization of Human Dermal Microvascular PericytesMicrovascular Research, 2001
- Peripheral and central vascular smooth muscle cells from rat lung exhibit different cytoskeletal protein profiles but similar growth factor requirementsJournal of Cellular Physiology, 1994
- Aging in man. Linear increase of a novel T cell subset defined by antiganglioside monoclonal antibody 3G5.Journal of Experimental Medicine, 1987